FFA
XFOR icon

Farther Finance Advisors’s X4 Pharmaceuticals XFOR Stock Holding History

Farther Finance Advisors’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-331
Closed -$1.44K – 6124
2026
Q1 		$1.44K Hold
331
– – ﹤0.01% 5009
2025
Q4 		$1.32K Buy
+331
New +$1.2K ﹤0.01% 4838

Other funds holding XFOR

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PFA
Pettinga Financial Advisors Evansville, Indiana $624M AUM 24.87% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Farther Finance Advisors's XFOR Position: Q2 2026 in Review

Farther Finance Advisors sold out of X4 Pharmaceuticals (XFOR) in Q2 2026, closing a stake of 331 shares — an estimated $1.44K sold.

Farther Finance Advisors first reported a position in XFOR in Q4 2025 and held it in 2 quarters. The position peaked at $1.44K in Q1 2026. 5 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Farther Finance Advisors reported no remaining X4 Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Farther Finance Advisors sold 331 X4 Pharmaceuticals shares in Q2 2026, an estimated $1.44K.
  • Farther Finance Advisors first reported a position in X4 Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Farther Finance Advisors's X4 Pharmaceuticals position peaked at $1.44K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.